NAPROXEN KINETICS AND DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS - A WITHIN-PATIENT STUDY

被引：19

作者：

VANDENOUWELAND, FA

GRIBNAU, FWJ

VANGINNEKEN, CAM

TAN, Y

VANDEPUTTE, LBA

机构：

[1] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,INST PHARMACOL,DIV CLIN PHARMACOL & PHARMACOKINET,6500 HB NIJMEGEN,NETHERLANDS

[2] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT MED,DIV RHEUMATOL,6500 HB NIJMEGEN,NETHERLANDS

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 43卷 / 01期

关键词：

D O I：

10.1038/clpt.1988.14

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：79 / 85

页数：7

共 22 条

[1]

DENKO CW, 1970, CLIN CHEM, V16, P54

[2]

KOBER A, 1980, MOL PHARMACOL, V18, P421

[3] STUDY OF THE MOLECULAR MECHANISM OF DECREASED LIVER SYNTHESIS OF ALBUMIN IN INFLAMMATION [J].

MOSHAGE, HJ ;

JANSSEN, JAM ;

FRANSSEN, JH ;

HAFKENSCHEID, JCM ;

YAP, SH .

JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (06) :1635-1641

[4]

PAULUS HE, 1985, ARTHRITIS ALLIED CON, P453

[5] PRELIMINARY CRITERIA FOR CLINICAL REMISSION IN RHEUMATOID-ARTHRITIS [J].

PINALS, RS ;

MASI, AT ;

LARSEN, RA .

ARTHRITIS AND RHEUMATISM, 1981, 24 (10) :1308-1315

[6]

ROPES M W, 1958, Bull Rheum Dis, V9, P175

[7] PROTEIN-BINDING AND DRUG CLEARANCE [J].

ROWLAND, M .

CLINICAL PHARMACOKINETICS, 1984, 9 :10-17

[8]

Rowland M, 1980, CLIN PHARMACOKINET, P65

[9]

RUNKEL R, 1974, CLIN PHARMACOL THER, V15, P261

[10] ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF NAPROXEN IN VARIOUS LABORATORY-ANIMALS AND HUMAN SUBJECTS [J].

RUNKEL, R ;

SEGRE, E ;

FORCHIELLI, E ;

CHAPLIN, M ;

BOOST, G .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (05) :703-+

← 1 2 3 →